Activating mutations in Fibroblast Growth Factor Receptor 2 (Fgfr2) [10–13] and inactivating mutations in Alpl, the gene for tissue nonspecific alkaline phosphatase (TNAP) [14–17] can cause craniosynostosis. This evidence concerns the gene ALPL and craniosynostosis.